Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Taxes (2017 - 2025)

Dr Reddys Laboratories (RDY) has 8 years of Current Taxes data on record, last reported at $28.2 million in Q1 2024.

  • For Q1 2024, Current Taxes rose 8.13% year-over-year to $28.2 million; the TTM value through Mar 2024 reached $28.2 million, up 8.13%, while the annual FY2025 figure was $35.0 million, 23.71% up from the prior year.
  • Current Taxes reached $28.2 million in Q1 2024 per RDY's latest filing, up from $26.1 million in the prior quarter.
  • Across five years, Current Taxes topped out at $28.2 million in Q1 2024 and bottomed at $7.9 million in Q1 2020.
  • Average Current Taxes over 5 years is $20.5 million, with a median of $21.5 million recorded in 2022.
  • Peak YoY movement for Current Taxes: skyrocketed 208.27% in 2020, then increased 8.13% in 2024.
  • A 5-year view of Current Taxes shows it stood at $7.9 million in 2020, then surged by 140.85% to $19.0 million in 2021, then rose by 12.75% to $21.5 million in 2022, then rose by 21.43% to $26.1 million in 2023, then rose by 8.13% to $28.2 million in 2024.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $28.2 million in Q1 2024, $26.1 million in Q1 2023, and $21.5 million in Q1 2022.